Literature DB >> 11810178

Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis.

V I Leussink1, U K Zettl, S Jander, R B Pepinsky, R R Lobb, G Stoll, K V Toyka, R Gold.   

Abstract

We characterized the early effects of anti-very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) antibody therapy on T cell infiltration and apoptosis in adoptive transfer experimental autoimmune neuritis of female Lewis rats. At the peak of disease, animals were treated with anti-VCAM-1 monoclonal antibody (mAb), anti-VLA-4 mAb, or the respective isotype mAb controls 18, 12, or 6 h before perfusion. Anti-VCAM-1 led to a rapid, significant increase of apoptotic T cells in the sciatic nerve with a maximum after 6 h, preceding the significant decrease of T cell infiltration seen after 18 h. This was accompanied by a significant reduction in mRNA levels for IFN-gamma and inducible nitric oxide synthase. The results for anti-VLA-4 treatment showed a similar trend. The early increase of T cell apoptosis following disruption of VLA-4/VCAM-1 interaction may reflect a novel signaling component of proapoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11810178     DOI: 10.1007/s004010100444

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

Review 1.  The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.

Authors:  Ahmad Reza Dorosty-Motlagh; Niyaz Mohammadzadeh Honarvar; Mohsen Sedighiyan; Mina Abdolahi
Journal:  J Mol Neurosci       Date:  2016-06-29       Impact factor: 3.444

Review 2.  Disease-modifying therapies and infectious risks in multiple sclerosis.

Authors:  Alexander Winkelmann; Micha Loebermann; Emil C Reisinger; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2016-03-04       Impact factor: 42.937

3.  Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes.

Authors:  Jennifer C Fleming; Feng Bao; Gediminas Cepinskas; Lynne C Weaver
Journal:  Inflamm Res       Date:  2010-03-07       Impact factor: 4.575

Review 4.  Infectious Complications of Novel Multiple Sclerosis Therapies.

Authors:  S N Levin; T B Kaplan
Journal:  Curr Infect Dis Rep       Date:  2017-02       Impact factor: 3.725

Review 5.  Role of beta7 integrins in intestinal lymphocyte homing and retention.

Authors:  G Gorfu; J Rivera-Nieves; K Ley
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

6.  Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.

Authors:  Jun-Ho Lee; Meital Halperin-Sheinfeld; Dolgar Baatar; Mohamed R Mughal; Hyun-Jin Tae; Jie-Wan Kim; Arnell Carter; Ana Lustig; Omri Snir; Gad Lavie; Eitan Okun; Mark P Mattson; Benjamin Sredni; Dennis D Taub
Journal:  Neuromolecular Med       Date:  2013-11-23       Impact factor: 3.843

7.  Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders.

Authors:  Aiden Haghikia; Moritz Perrech; Bartosz Pula; Sabrina Ruhrmann; Anja Potthoff; Norbert H Brockmeyer; Susan Goelz; Heinz Wiendl; Hans Lindå; Tjalf Ziemssen; Sergio E Baranzini; Tor-Björn Käll; Dietmar Bengel; Tomas Olsson; Ralf Gold; Andrew Chan
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

Review 8.  Environmental Influencers, MicroRNA, and Multiple Sclerosis.

Authors:  Eiman Ma Mohammed
Journal:  J Cent Nerv Syst Dis       Date:  2020-01-20

Review 9.  Integrin-directed antibody-based immunotherapy: focus on VLA-4.

Authors:  Wilson Savino; Beatriz Chaves; Adriana Cesar Bonomo; Vinicius Cotta-de-Almeida
Journal:  Immunother Adv       Date:  2021-02-09

Review 10.  The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS).

Authors:  Mohammed A Al Jumah; Mohamed H Abumaree
Journal:  Int J Mol Sci       Date:  2012-07-24       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.